Biomarkers can help a treatment team to determine the best treatment for a patient, see how the patient is responding, and assist in creating a care plan. New tumor markers are being identified with more frequency, so all tumor markers may not yet be reflected on this list.
- ALK (anaplastic lymphoma kinase).
- BRAF (B-RAF proto-oncogene, serine/threonine kinase).
- EGFR (epidermal growth factor receptor).
- FGFR (Fibroblast growth factor receptor).
- HER2 (human epidermal growth factor receptor 2).
- KRAS (Kirsten rat sarcoma viral oncogene homolog).
- MET (MET-proto-oncogene).
- NTRK (Neurotrophic receptor tyrosine kinase 1).
- PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha).
- Programmed death ligand 1 (PD-L1)
- RET (RET-proto-oncogene).
- ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase)